Megan M. Harper

Public Health and Preventive Medicine
800 Rose St
Lexington, KY 40536

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Treatment at an Academic Medical Center Eliminates Survival Disparities for Appalachian Kentuckians with Pancreatic Ductal Adenocarcinoma.

Treatment at an Academic Medical Center Eliminates Survival Disparities for Appalachian Kentuckians with Pancreatic Ductal Adenocarcinoma.

Journal: Journal of Appalachian health
Published: December 06, 2024

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer.

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer.

Journal: Molecular oncology
Published: November 03, 2024

Development of a Novel Protocol for Germline Testing in Pancreatic Cancer.

Development of a Novel Protocol for Germline Testing in Pancreatic Cancer.

Journal: Annals of surgical oncology
Published: May 20, 2024

Creation of EGD-Derived Gastric Cancer Organoids to Predict Treatment Responses.

Creation of EGD-Derived Gastric Cancer Organoids to Predict Treatment Responses.

Journal: Cancers
Published: May 10, 2023

The Development of Investigator-Initiated Clinical Trials in Surgical Oncology.

The Development of Investigator-Initiated Clinical Trials in Surgical Oncology.

Journal: Surgical oncology clinics of North America
Published: November 21, 2022

A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease.

A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease.

Journal: Annals of surgical oncology
Published: May 12, 2022

Endogenous Pancreatic Cancer Cell PD-1 Activates MET and Induces Epithelial-Mesenchymal Transition to Promote Cancer Progression.

Endogenous Pancreatic Cancer Cell PD-1 Activates MET and Induces Epithelial-Mesenchymal Transition to Promote Cancer Progression.

Journal: Cancers
Published: May 06, 2022

Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies.

Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies.

Journal: Journal of clinical medicine
Published: April 13, 2022

Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells.

Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells.

Journal: PloS one
Published: June 17, 2021

Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application.

Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application.

Journal: Journal of the American College of Surgeons
Published: November 13, 2020

MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages.

MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages.

Journal: Oncogene
Published: November 27, 2018
Showing 1-11 of 11

Last Updated: 09/26/2026